This inventor holds 1 USPTO granted patent and 6 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Ocera Therapeutics, Inc.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Laurene Wang: Innovator in Oral Formulations for Liver Disorders
Introduction
Laurene Wang is a notable inventor based in Chapel Hill, NC (US). She has made significant contributions to the field of medical formulations, particularly in the treatment of liver diseases. Her innovative work focuses on alternative administration routes for essential compounds used in clinical settings.
Latest Patents
Laurene Wang holds a patent for "Formulations of L-ornithine phenylacetate." This patent describes oral formulations of L-ornithine phenylacetate and methods of using these formulations. The invention provides an alternative to the standard intravenous administration of L-ornithine phenylacetate for treating hyperammonemia in patients with various acute and chronic liver diseases. These conditions include acute liver failure, liver cirrhosis, liver decompensation, portal hypertension, hepatic encephalopathy, and urea cycle disorders. She has 1 patent to her name.
Career Highlights
Laurene Wang is currently associated with Ocera Therapeutics, Inc., where she continues to advance her research and development efforts. Her work is pivotal in improving treatment options for patients suffering from liver-related disorders.
Collaborations
Laurene collaborates with esteemed colleagues, including Stanley Bukofzer and Linda S Grais. Their combined expertise contributes to the innovative solutions being developed at Ocera Therapeutics.
Conclusion
Laurene Wang's contributions to the field of medical formulations highlight her commitment to improving patient care through innovative solutions. Her work in developing oral formulations for liver disease treatment represents a significant advancement in medical science.